Testing effectiveness (Phase 2)WithdrawnNCT04944173
What this trial is testing
SCION: SABR and Checkpoint Inhibition of NSCLC
Who this might be right for
Non Small Cell Lung CancerCarcinoma, Non-Small-Cell LungNon-small Cell Lung Cancer Stage I+4 more
University of British Columbia